source
- Roche warns Germany faces last chance to regain pharma investment confidenceRoche has said that recent German healthcare reforms threaten the country's attractiveness for pharmaceutical investment. The company paused its own German investment plans after the reforms were a…
- Marengo's bispecific antibody invikafusp alfa shows tumor shrinkage in 8 cancer types in Phase 2Marengo Therapeutics presented Phase 2 data for its bispecific antibody invikafusp alfa at the European Society for Medical Oncology meeting in Madrid. The study, part of the Start-001 first‑in‑hum…